These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22112349)

  • 1. Therapeutic strategies targeting endothelial function in humans: clinical implications.
    Lee R; Channon KM; Antoniades C
    Curr Vasc Pharmacol; 2012 Jan; 10(1):77-93. PubMed ID: 22112349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel agents targeting nitric oxide.
    Kampoli AM; Tousoulis D; Tentolouris C; Stefanadis C
    Curr Vasc Pharmacol; 2012 Jan; 10(1):61-76. PubMed ID: 22112348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapies targeting vascular endothelium.
    Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
    Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide and oxidative stress in vascular disease.
    Förstermann U
    Pflugers Arch; 2010 May; 459(6):923-39. PubMed ID: 20306272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction: potential clinical implications.
    Tousoulis D; Koutsogiannis M; Papageorgiou N; Siasos G; Antoniades C; Tsiamis E; Stefanadis C
    Minerva Med; 2010 Aug; 101(4):271-84. PubMed ID: 21030938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of endothelial function: targets for nutritional and pharmacological interventions.
    Sudano I; Spieker LE; Hermann F; Flammer A; Corti R; Noll G; Lüscher TF
    J Cardiovasc Pharmacol; 2006; 47 Suppl 2():S136-50; discussion S172-6. PubMed ID: 16794451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.
    Thomas SR; Witting PK; Drummond GR
    Antioxid Redox Signal; 2008 Oct; 10(10):1713-65. PubMed ID: 18707220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-mediated endothelial dysfunction--is there need to treat?
    Tiefenbacher CP; Kreuzer J
    Curr Vasc Pharmacol; 2003 Jun; 1(2):123-33. PubMed ID: 15320839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction: clinical strategies for treating oxidant stress.
    Fenster BE; Tsao PS; Rockson SG
    Am Heart J; 2003 Aug; 146(2):218-26. PubMed ID: 12891188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
    Antoniades C; Bakogiannis C; Leeson P; Guzik TJ; Zhang MH; Tousoulis D; Antonopoulos AS; Demosthenous M; Marinou K; Hale A; Paschalis A; Psarros C; Triantafyllou C; Bendall J; Casadei B; Stefanadis C; Channon KM
    Circulation; 2011 Jul; 124(3):335-45. PubMed ID: 21730307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches.
    Tousoulis D; Simopoulou C; Papageorgiou N; Oikonomou E; Hatzis G; Siasos G; Tsiamis E; Stefanadis C
    Pharmacol Ther; 2014 Dec; 144(3):253-67. PubMed ID: 24928320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.
    Chłopicki S; Gryglewski RJ
    Pharmacol Rep; 2005; 57 Suppl():86-96. PubMed ID: 16415489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles.
    Tiefenbacher CP; Friedrich S; Bleeke T; Vahl C; Chen X; Niroomand F
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1425-32. PubMed ID: 14644762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.
    Tousoulis D; Papageorgiou N; Androulakis E; Siasos G; Latsios G; Tentolouris K; Stefanadis C
    J Am Coll Cardiol; 2013 Aug; 62(8):667-76. PubMed ID: 23948511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus and vascular endothelial dysfunction: current perspectives.
    Tousoulis D; Kampoli AM; Stefanadis C
    Curr Vasc Pharmacol; 2012 Jan; 10(1):19-32. PubMed ID: 22112354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
    Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
    Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering.
    Margaritis M; Channon KM; Antoniades C
    Antioxid Redox Signal; 2014 Mar; 20(8):1198-215. PubMed ID: 24111702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
    Woodman RJ; Chew GT; Watts GF
    Drugs; 2005; 65(1):31-74. PubMed ID: 15610050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.
    Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB
    J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and endothelial function: therapeutic interventions.
    Tousoulis D; Briasoulis A; Papageorgiou N; Tsioufis C; Tsiamis E; Toutouzas K; Stefanadis C
    Recent Pat Cardiovasc Drug Discov; 2011 May; 6(2):103-14. PubMed ID: 21513492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.